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Pancreatic disorders, such as acute and chronic pancreatitis
and pancreatic cancer, are until now challenging diseases
to manage, with signi�cant burdens of morbidity, mortality
rate, and high �nancial costs. Acute pancreatitis (AP) is
still a common and potentially fatal disease with nonspeci�c
treatment and unpredictable prognosis. In spite of signi�cant
improvement in understanding the basic pathophysiology of
the disease and advances in the diagnosis and management
of acute pancreatitis, the mortality rate has remained stable
since the 1970s. Chronic pancreatitis (CP), resulting in
a slow irreversible damage of the organ associated with
gradual declines in digestive enzyme production, is themajor
cause of pancreatic exocrine insuﬃciency in adults. Finally,
pancreatic cancer is known as a devastating process with only
6-month median survival aer diagnosis.
In the present special issue,some recent advances in
research concerning pancreatic diseases are presented. Croa-
tian authors discussed epidemiology of AP in the North
Adriatic Region of Croatia. ey showed epidemiological
characteristics typical of Mediterranean countries with pre-
dominant biliary etiology.
Early prediction of severity of acute pancreatitis (AP) by
a simple unique laboratory test would be very helpful as it
could direct management from the very beginning and at
the end improve the outcome. Commonly accepted scales
estimating the AP severity are extremely hard to use in
clinical practice. For this reason, it is understandable why
further attempts to �nd a parameter or a set of parameters
useful in diagnosis and prognosis in AP are so necessary.
Despite the importance of early prognosis, many patients
initially identi�ed as having a mild disease progress to
severe acute pancreatitis (SAP) over time. Many biochemical
parameters (including C-reactive protein (CRP), procalci-
tonin, and trypsinogen activation peptide (TAP)) have been
evaluated in the severity assessment of AP.
In the present issue, authors discussed prognostic value
of interleukins (IL) 6, 8, and 10, soluble receptor for tumor
necrosis factor (sTNFr), pancreatic elastase (E1), and C-
reactive protein (CRP) as predictors of systemic compli-
cations in patients with AP. ey found that IL-6, IL-8,
IL-10, and sTNFr measured on admission and CRP and
pancreatic elastase measured on the third day of admission
represent valuable prognostic factors in the determination
of severity and systemic complications in patients with AP.
Recently, parameters showing distortion of water balance in
the course of AP have been a subject of research and clinical
observations and were found very promising in severity and
death prediction.
Although the pathogenesis of post-ERCP pancreatitis is
not clearly understood, it seems that the patient�s in�am-
matory response to pancreatic duct imaging and instrumen-
tation plays a critical role. Several studies pointed out to
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special factors, which put an individual in high risk for
the development of post-ERCP pancreatitis. e history of
post-ERCP pancreatitis as an independent risk factor for a
new episode of post-ERCP pancreatitis seems to be very
important. On the other hand, some individuals can have
a genetically predisposed susceptibility for this particular
complication. However, in the article published in this issue,
the authorswere not able to associate the role of SPINK1N34S
mutation with post-ERCP pancreatitis.
Pancreatic cancer (PC) is one of the cancers of limited
occurrence; however, worldwide over 200000 people die
annually of this disease. e highest incidence and mortality
rates of pancreatic cancer are found in developed countries.
In the United States, pancreatic cancer is the fourth leading
cause of cancer death, and in Europe it is the sixth. PC
occurs three times as oen in high-income countries as in
those of middle and low income. erefore, understanding
the etiology and identifying the risk factors remain essential
for the primary prevention of this disease. e risk factors,
which can be easily eliminated, include tobacco smoking,
obesity, and diabetes mellitus.e extent to which diet aﬀects
pancreatic cancer risk is still unclear.
e authors of the article included in the present issue
have shown a correlation between PC and tobacco smoking
(0.55 and 0.44). ey also discussed that high consumptions
of fats, sugar, and alcohol are potential risk factors for PC.
erefore, they suggest that positive changes in the diet
such as lowering red meat consumption and increasing fruit
consumption could in�uence incidence and reduction in
future years.
Furthermore, other investigators discussed some inter-
esting data concerning some microenvironmental elements,
which could be involved in the development of pancreatic
cancer. It is well known that growth of dense, collagen-rich,
extracellular matrix and stroma, known as the desmoplastic
reaction, creates a uniquemicroenvironment promoting both
tumour growth, and metastatic spread and forms a barrier
to speci�c chemotherapy drug penetration. e authors
discussed newdevelopments in the �ght against desmoplastic
reaction, including inhibitors of the epidermal growth factor,
�broblast growth factor as well as new molecular targets
like CD40 agonist and their eﬀects on T cells, extracellular
matrix modifying enzymes such as LOXL2 inhibitor, and
novel tumor-penetrating peptides for delivery of drugs.
A group of scientists also described the involvement of
macrophages in angiogenesis, process tumor growth and
invasion of cancer cells. Macrophages are the source of
angiogenic factors like VEGF and alsoMMP9, which degrade
extracellularmatrix.erefore,macrophages in�ltrating pan-
creatic tumor are another important factor promotingmetas-
tases. It was established that among many factors in�u-
encing tumor microenvironment c-Met receptor, in�ltrating
macrophages and MMP2 have signi�cant in�uence on the
development and invasion of pancreatic cancer.
Endoscopic ultrasound-guided �ne needle aspiration
(EUS-FNA) is now considered as one of the most useful
methods for histological diagnosis and staging of pancre-
atic cancers. e Japanese discussed the usefulness, cost-
eﬀectiveness, and accuracy of EUS-FNA as a diagnostic
modality for evaluating pancreatic tumors. ey also under-
lined the role of molecular biological analyses for the diagno-
sis of PC. Other authors showed the utility of percutaneous
ultrasonography-guided biopsy as a diagnostic tool for PC;
however, it seems that this method should be rather reserved
for nonresectable tumors.
We trust that the data presented in this special issue
will help in understanding pancreatic disorder pathogenesis,
especially microenvironment elements involved in the devel-
opment of pancreatic cancer tumor. is hopefully will give
new ideas for the development of new therapeutic strategies
in pancreatic disorders.
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